---
title: "European Herbal Medicine Evidence Reference Guide"
category: "Regulatory & Evidence Reference"
tags:
  [
    "ema",
    "hmpc",
    "eu_herbal_medicines",
    "clinical_evidence",
    "regulatory_reference",
  ]
date: "2025-11-14"
source: "European Medicines Agency (EMA) herbal medicines database and HMPC assessments (https://www.ema.europa.eu/en/human-regulatory/herbal-products)"
---

# European Herbal Medicine Evidence Reference Guide

*Based on European Medicines Agency (EMA) Herbal Monographs and Scientific Assessments*

## Introduction

This comprehensive reference guide synthesizes evidence-based information on herbal medicines approved and assessed by the European Medicines Agency (EMA). The guide organizes herbal substances by therapeutic area, providing clinicians and researchers with authoritative information on efficacy, safety, and clinical application based on European Union herbal monographs and scientific assessments.

The EMA's Committee on Herbal Medicinal Products (HMPC) is responsible for compiling and assessing scientific data on herbal medicines, establishing community herbal monographs that serve as the scientific basis for registration and authorization of herbal medicinal products in the European Union. 

Each monograph follows a standardized structure containing:
- Therapeutic indications
- Posology and method of administration
- Contraindications
- Special warnings and precautions for use
- Clinical efficacy and safety data 

---

## Section 1: Cough and Cold

### Primula root (Primulae radix)

**Botanical Source:** *Primula veris* L.; *Primula elatior* (L.) Hill  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Traditional herbal medicinal product for relief of cough associated with the common cold.  
**Posology:** Oral use. Specific dosage depends on preparation type.  
**Safety:** Generally well-tolerated. May cause gastrointestinal discomfort in sensitive individuals.  
**Special Considerations:** Not recommended for children under 12 years without medical supervision.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/primulae-radix](https://www.ema.europa.eu/en/medicines/herbal/primulae-radix)

### Primula flower (Primulae flos)

**Botanical Source:** *Primula veris* L.; *Primula elatior* (L.) Hill  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Traditional use for relief of cough and cold symptoms.  
**Clinical Evidence:** Long-standing traditional use supported by pharmacological data on expectorant properties.  
**Special Warnings:** Hypersensitivity to primrose family plants is a contraindication.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/primulae-flos](https://www.ema.europa.eu/en/medicines/herbal/primulae-flos)

### Ribwort Plantain (Plantaginis lanceolatae folium)

**Botanical Source:** *Plantago lanceolata* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of upper respiratory tract infections associated with common cold.  
**Mechanism of Action:** Mucilage content provides soothing effect on irritated mucous membranes.  
**Duration of Use:** Short-term use for acute symptoms.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/plantaginis-lanceolatae-folium](https://www.ema.europa.eu/en/medicines/herbal/plantaginis-lanceolatae-folium)

### Pelargonium root (Pelargonii radix)

**Botanical Source:** *Pelargonium sidoides* DC; *Pelargonium reniforme* Curt.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of acute bronchitis and common cold in adults and children over 1 year.  
**Clinical Evidence:** Multiple clinical trials support efficacy in reducing duration and severity of respiratory symptoms.  
**Safety Profile:** Generally well-tolerated with mild gastrointestinal effects as most common adverse reactions.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/pelargonii-radix](https://www.ema.europa.eu/en/medicines/herbal/pelargonii-radix)

### Ivy leaf (Hederae helicis folium)

**Botanical Source:** *Hedera helix* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Traditional herbal medicinal product for relief of cough associated with the common cold.  
**Active Constituents:** Saponins with expectorant and mucolytic properties.  
**Special Warnings:** Not recommended for children under 2 years of age.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/hederae-helicis-folium](https://www.ema.europa.eu/en/medicines/herbal/hederae-helicis-folium)

### Eucalyptus Oil (Eucalypti aetheroleum)

**Botanical Source:** *Eucalyptus globulus* Labill.; *Eucalyptus polybractea* R.T. Baker; *Eucalyptus smithii* R.T. Baker  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of common cold and minor pain and inflammation.  
**Administration:** Can be used orally or topically depending on preparation.  
**Contraindications:** Hypersensitivity to eucalyptus oil or any of the excipients.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/eucalypti-aetheroleum](https://www.ema.europa.eu/en/medicines/herbal/eucalypti-aetheroleum)

### Linden Flower (Tiliae flos)

**Botanical Source:** *Tilia cordata* Miller; *Tilia platyphyllos* Scop.; *Tilia x vulgaris* Heyne  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of minor upper respiratory tract infections and cough associated with cold; relief of mild symptoms of mental stress and to aid sleep.  
**Traditional Use:** Long-standing traditional use as a sedative and for respiratory conditions.  
**Special Precautions:** Not recommended for children under 12 years of age.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/tiliae-flos](https://www.ema.europa.eu/en/medicines/herbal/tiliae-flos)

---

## Section 2: Gastrointestinal Disorders

### Ginger (Zingiberis rhizoma)

**Botanical Source:** *Zingiber officinale* Roscoe  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Prevention of nausea and vomiting in motion sickness in adults.  
**Clinical Evidence:** The HMPC conclusions on the use of ginger medicines for the prevention of nausea and vomiting in motion sickness are based on their 'well-established use'.   
**Safety Profile:** The available evidence suggests that ginger is a safe and effective treatment for nausea and vomiting.   
**Contraindications:** Not recommended in adolescents and children below 18 years due to insufficient data on safety and efficacy.   
**Quality Standards:** The herbal substance ginger must comply with the monograph of the European Pharmacopoeia.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/zingiberis-rhizoma](https://www.ema.europa.eu/en/medicines/herbal/zingiberis-rhizoma)

### Peppermint Leaf (Menthae piperitae folium)

**Botanical Source:** *Mentha x piperita* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of minor spasms associated with gastrointestinal disorders.  
**Mechanism of Action:** Antispasmodic effects on smooth muscle of the gastrointestinal tract.  
**Administration:** Oral use for gastrointestinal complaints.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/menthae-piperitae-folium](https://www.ema.europa.eu/en/medicines/herbal/menthae-piperitae-folium)

### Peppermint Oil (Menthae piperitae aetheroleum)

**Botanical Source:** *Mentha x piperita* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph and European Union list entry  
**Therapeutic Indications:** Relief of symptoms of tension-type headache; relief of irritable bowel syndrome symptoms; relief of minor spasms associated with gastrointestinal disorders.  
**Clinical Applications:** Multiple therapeutic areas including pain and inflammation, skin disorders, cough and cold, and gastrointestinal disorders.  
**Special Warnings:** Not for use in children under 12 years of age.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/menthae-piperitae-aetheroleum](https://www.ema.europa.eu/en/medicines/herbal/menthae-piperitae-aetheroleum)

### Artichoke Leaf (Cynarae folium)

**Botanical Source:** *Cynara cardunculus* L.; syn. *C. scolymus* L.  
**EMA Status:** Ongoing call for scientific data (C)  
**Evidence Level:** Under assessment  
**Therapeutic Indications:** Traditional use for digestive complaints and dyspepsia.  
**Research Status:** Currently under scientific review by HMPC for evidence assessment.  
**EMA Assessment Page:** [https://www.ema.europa.eu/en/medicines/herbal/cynarae-folium](https://www.ema.europa.eu/en/medicines/herbal/cynarae-folium)

### Chamomile Flower (Matricariae flos)

**Botanical Source:** *Matricaria recutita* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of mild gastrointestinal spasms; relief of minor skin inflammations; relief of minor mouth and throat inflammations; relief of cough associated with common cold.  
**Multi-system Effects:** Approved for use in multiple therapeutic areas including gastrointestinal, skin, oral, and respiratory conditions.  
**Safety Profile:** Generally well-tolerated with rare allergic reactions in sensitive individuals.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/matricariae-flos](https://www.ema.europa.eu/en/medicines/herbal/matricariae-flos)

### Dandelion (Taraxaci officinalis radix)

**Botanical Source:** *Taraxacum officinale* F.H. Wigg.  
**EMA Status:** Assessment finalised (F) / Rapporteur assigned (R)  
**Evidence Level:** European Union herbal monograph (multiple parts)  
**Therapeutic Indications:** Loss of appetite; urinary tract and genital disorders; gastrointestinal disorders.  
**Different Plant Parts:** Both root and herb with leaf are assessed for different indications.  
**Traditional Use:** Long-standing use as a digestive bitter and diuretic.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/taraxaci-officinalis-radix](https://www.ema.europa.eu/en/medicines/herbal/taraxaci-officinalis-radix)

---

## Section 3: Urinary Tract and Genital Disorders

### Nettle Root (Urticae radix)

**Botanical Source:** *Urtica dioica* L.; *Urtica urens* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) in adults.  
**Clinical Evidence:** Supported by clinical studies demonstrating improvement in urinary flow and reduction in nocturia.  
**Duration of Use:** Long-term treatment may be necessary for symptomatic relief.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/urticae-radix](https://www.ema.europa.eu/en/medicines/herbal/urticae-radix)

### Saw Palmetto Fruit (Sabalis serrulatae fructus)

**Botanical Source:** *Serenoa repens* (W.Bartram) Small (syn. *Sabal serrulata* (Michx.) Schult.f.)  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) in adults.  
**Mechanism of Action:** Inhibition of 5-alpha-reductase and anti-inflammatory effects.  
**Clinical Applications:** Primarily used for urinary symptoms in aging men.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/sabalis-serrulatae-fructus](https://www.ema.europa.eu/en/medicines/herbal/sabalis-serrulatae-fructus)

### Pumpkin Seed (Cucurbitae semen)

**Botanical Source:** *Cucurbita pepo* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of lower urinary tract symptoms related to benign prostatic hyperplasia.  
**Traditional Use:** Long-standing traditional use for urinary complaints and prostate health.  
**Safety Profile:** Generally well-tolerated with minimal adverse effects.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/cucurbitae-semen](https://www.ema.europa.eu/en/medicines/herbal/cucurbitae-semen)

### Cranberry (Vaccinii macrocarpi fructus)

**Botanical Source:** *Vaccinium macrocarpon* Aiton  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Prevention of recurrent urinary tract infections in adult women.  
**Mechanism of Action:** Prevention of bacterial adhesion to uroepithelial cells.  
**Clinical Evidence:** Multiple clinical trials support prophylactic use in recurrent UTIs.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/vaccinii-macrocarpi-fructus](https://www.ema.europa.eu/en/medicines/herbal/vaccinii-macrocarpi-fructus)

### Orthosiphon (Orthosiphonis folium)

**Botanical Source:** *Orthosiphon aristatus* (Blume) Miq. var. aristatus  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of lower urinary tract disorders characterized by irritation.  
**Traditional Use:** Traditional herbal medicinal product for urinary conditions.  
**Development Status:** The European Medicines Agency is currently developing this information.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/orthosiphonis-folium](https://www.ema.europa.eu/en/medicines/herbal/orthosiphonis-folium)

---

## Section 4: Sleep Disorders and Mental Stress

### Valerian Root (Valerianae radix)

**Botanical Source:** *Valeriana officinalis* L.  
**EMA Status:** Ongoing call for scientific data (C)  
**Evidence Level:** European Union herbal monograph and European Union list entry  
**Therapeutic Indications:** Relief of mild symptoms of mental stress and to aid sleep.  
**Clinical Evidence:** Multiple clinical studies support efficacy for sleep disorders and anxiety.  
**Special Considerations:** Long-term use is possible but should be monitored.   
**EMA Assessment:** Date of adoption of European Union list entry by HMPC: 02/02/2016.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/valerianae-radix](https://www.ema.europa.eu/en/medicines/herbal/valerianae-radix)

### Passion Flower (Passiflorae herba)

**Botanical Source:** *Passiflora incarnata* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of mild symptoms of mental stress and to aid sleep.  
**Mechanism of Action:** Modulation of GABAergic system and other neurotransmitter pathways.  
**Safety Profile:** Generally well-tolerated with minimal sedation or dependence potential.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/passiflorae-herba](https://www.ema.europa.eu/en/medicines/herbal/passiflorae-herba)

### Lemon Balm (Melissae folium)

**Botanical Source:** *Melissa officinalis* L.  
**EMA Status:** Ongoing call for scientific data (C)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of mild symptoms of mental stress and to aid sleep; relief of mild gastrointestinal spasms.  
**Multi-system Effects:** Approved for both nervous system and gastrointestinal applications.  
**Traditional Use:** Long-standing traditional use as a calming and digestive herb.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/melissae-folium](https://www.ema.europa.eu/en/medicines/herbal/melissae-folium)

### California Poppy (Eschscholziae herba)

**Botanical Source:** *Eschscholzia californica* Cham.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of mild symptoms of mental stress and to aid sleep.  
**Clinical Applications:** Used for sleep disorders and temporary insomnia; mental stress and mood disorders.  
**Safety Profile:** Generally well-tolerated with minimal risk of dependence.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/eschscholziae-herba](https://www.ema.europa.eu/en/medicines/herbal/eschscholziae-herba)

---

## Section 5: Pain and Inflammation

### Willow Bark (Salicis cortex)

**Botanical Source:** *Salix* [various species including *S. purpurea* L.; *S. daphnoides* Vill.; *S. fragilis* L.]  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of minor articular pain and fever associated with common cold.  
**Active Constituents:** Salicin derivatives with analgesic and anti-inflammatory properties.  
**Clinical Evidence:** Well-established use for pain relief, particularly in osteoarthritis and back pain.  
**Contraindications:** Hypersensitivity to salicylates; not recommended for children under 18 years with viral infections due to Reye's syndrome risk.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex](https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex)

### Arnica Flower (Arnicae flos)

**Botanical Source:** *Arnica montana* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of bruises, sprains, and localised muscle pain.  
**Administration:** External use only - never for internal use due to toxicity.  
**Special Warnings:** For cutaneous use only; contraindicated in individuals with hypersensitivity to Asteraceae/Compositae family plants.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/arnicae-flos](https://www.ema.europa.eu/en/medicines/herbal/arnicae-flos)

### Capsicum (Capsici fructus)

**Botanical Source:** *Capsicum annuum* L. var. minimum (Miller) Heiser  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of muscle and joint pain; neuralgia.  
**Mechanism of Action:** Depletion of substance P in nerve endings, reducing pain transmission.  
**Administration:** Topical use for pain and inflammation.  
**Special Precautions:** Avoid contact with eyes and mucous membranes.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/capsici-fructus](https://www.ema.europa.eu/en/medicines/herbal/capsici-fructus)

### Comfrey Root (Symphyti radix)

**Botanical Source:** *Symphytum officinale* L.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of bruises and sprains.  
**Safety Concerns:** Contains pyrrolizidine alkaloids with potential hepatotoxicity - restricted to external use only.  
**Special Warnings:** For cutaneous use only; contraindicated in individuals with hypersensitivity.   
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/symphyti-radix](https://www.ema.europa.eu/en/medicines/herbal/symphyti-radix)

---

## Section 6: Skin Disorders and Minor Wounds

### Calendula Flower (Calendulae flos)

**Botanical Source:** *Calendula officinalis* L.  
**EMA Status:** Ongoing call for scientific data (C)  
**Evidence Level:** European Union herbal monograph and European Union list entry  
**Therapeutic Indications:** Minor wounds, minor skin inflammations, minor burns, and minor skin infections.  
**Mechanism of Action:** Anti-inflammatory, antimicrobial, and wound-healing properties.  
**Clinical Applications:** Widely used in dermatological preparations for skin healing.  
**EMA Assessment:** Date of adoption of Community list entry by HMPC: 06/03/08.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/calendulae-flos](https://www.ema.europa.eu/en/medicines/herbal/calendulae-flos)

### Hamamelis (Witch Hazel) - Multiple Preparations

**Botanical Source:** *Hamamelis virginiana* L.  
**EMA Status:** Assessment finalised (F) for multiple preparations  
**Evidence Level:** European Union herbal monograph and list entries  
**Preparations Available:**
- **Bark (Hamamelidis cortex):** For minor skin inflammations and minor skin injuries
- **Leaf (Hamamelidis folium):** For minor skin inflammations and circulatory disorders
- **Distillate (Hamamelidis folium et cortex aut ramunculus destillatum):** For minor skin inflammations, minor skin injuries, and eye discomfort  
**Active Constituents:** Tannins with astringent and anti-inflammatory effects.  
**Special Warnings:** For external use only in undiluted form.  
**EMA Monograph (Bark):** [https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex](https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex)

### Centella (Gotu Kola) (Centellae asiaticae herba)

**Botanical Source:** *Centella asiatica* (L.) Urb.  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Minor wounds, minor burns, and minor skin infections.  
**Mechanism of Action:** Stimulation of collagen synthesis and wound healing processes.  
**Clinical Evidence:** Supported by clinical trials for wound healing and scar reduction.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/centellae-asiaticae-herba](https://www.ema.europa.eu/en/medicines/herbal/centellae-asiaticae-herba)

### Tea Tree Oil (Melaleucae aetheroleum)

**Botanical Source:** *Melaleuca alternifolia* (Maiden and Betche) Cheel  
**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph and European Union list entry  
**Therapeutic Indications:** Minor wounds, minor burns, and minor skin infections; minor mouth and throat inflammations.  
**Antimicrobial Properties:** Broad-spectrum antimicrobial activity against bacteria, fungi, and viruses.  
**Special Warnings:** For external use only; dilution required to avoid skin irritation.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/melaleucae-aetheroleum](https://www.ema.europa.eu/en/medicines/herbal/melaleucae-aetheroleum)

---

## Section 7: Complex Herbal Combinations

### Herbal Tea Combinations for Cough and Cold (Species pectorales)

**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of symptoms of common cold and cough.  
**Composition:** Specific combinations of herbs traditionally used for respiratory conditions.  
**Assessment Date:** Finalised assessment published on 09/02/2023.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/combination-species-pectorales](https://www.ema.europa.eu/en/medicines/herbal/combination-species-pectorales)

### Herbal Tea Combinations for Sedatives (Species sedativae)

**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of mild symptoms of mental stress and to aid sleep.  
**Composition:** Combinations of herbs with sedative properties such as valerian, passion flower, and lemon balm.  
**Clinical Evidence:** Traditional use supported by pharmacological data on individual components.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/species-sedativae](https://www.ema.europa.eu/en/medicines/herbal/species-sedativae)

### Herbal Tea Combinations for Loss of Appetite (Species amarae)

**EMA Status:** Assessment finalised (F)  
**Evidence Level:** European Union herbal monograph  
**Therapeutic Indications:** Relief of loss of appetite and digestive complaints.  
**Composition:** Bitter herbs traditionally used to stimulate digestion and appetite.  
**Mechanism of Action:** Stimulation of digestive enzyme secretion and gastric motility.  
**EMA Monograph:** [https://www.ema.europa.eu/en/medicines/herbal/species-amarae](https://www.ema.europa.eu/en/medicines/herbal/species-amarae)

---

## Section 8: Evidence Assessment Framework

### HMPC Assessment Categories

The EMA's Committee on Herbal Medicinal Products (HMPC) uses specific status codes to indicate the stage of assessment for each herbal substance:

- **F: Assessment finalised** - Complete scientific assessment resulting in EU herbal monograph or list entry
- **D: Draft under discussion** - Assessment in progress, draft monograph under consideration
- **C: Ongoing call for scientific data** - Additional evidence needed for complete assessment
- **R: Rapporteur assigned** - Assessment process initiated with designated rapporteur
- **B: Background information** - Preliminary information gathering phase

### Levels of Scientific Evidence

EMA herbal assessments recognize different levels of evidence:

1. **Well-established use** - Substantial clinical evidence from multiple studies
2. **Traditional use** - Long-standing traditional use (typically >30 years in EU) with plausible mechanism
3. **Draft evidence** - Under evaluation with preliminary data
4. **Ongoing research** - Call for additional scientific data

### Quality Standards

All herbal medicinal products must comply with strict quality requirements including:

- Identity, purity, and quality testing according to European Pharmacopoeia
- Good Agricultural and Collection Practices (GACP)
- Good Manufacturing Practices (GMP)
- Standardized active constituent content where appropriate

---

## Appendix A: Complete Herbal Inventory

*This section contains the complete inventory of herbal medicines assessed by EMA as of November 13, 2025, organized alphabetically by Latin name.*

| Latin Name | Common Name | Botanical Source | Therapeutic Area | Status | Assessment Outcome | Last Updated |
|------------|-------------|------------------|------------------|--------|-------------------|-------------|
| Absinthii herba | Wormwood | *Artemisia absinthium* L. | Loss of appetite; Gastrointestinal disorders | F | EU herbal monograph | 18/09/2024 |
| Achilleae millefolii herba | Yarrow | *Achillea millefolium* L. | Multiple indications | F | EU herbal monograph & list entry | 07/04/2021 |
| Adhatodae vasicae folium | Malabar-nut leaf | *Adhatoda vasica* Nees | Not specified | F | Public statement | 30/04/2018 |
| Aesculus hippocastanum semen | Horse-chestnut seed | *Aesculus hippocastanum* L. | Circulatory disorders | F | EU herbal monograph | 24/07/2020 |
| Agni casti fructus | Agnus Castus Fruit | *Vitex agnus-castus* L. | Urinary tract and genital disorders | C | EU herbal monograph | 15/02/2024 |
| Agropyri repentis rhizoma | Couch grass rhizome | *Agropyron repens* (L.) P. Beauv. | Urinary tract and genital disorders | F | EU herbal monograph | 03/10/2022 |

